3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Ovarian Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Castration-sensitive Prostate Cancer
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
10
Leucovorin
9
Fluorouracil
9
Specimen Handling
6
Cetuximab
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
cemiplimab
3
Pemetrexed
3
fludarabine
2
dehydroftorafur
2
aldesleukin
2
Surveys and Questionnaires
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipiracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
niraparib
×
30 days
×
Clear all
No trials found.